# Ionis Pharmaceuticals, Inc. (IONS): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for Ionis Pharmaceuticals, Inc. (IONS) is 4/100, ranked against 24,000+ stocks in 35 markets (Quality 22, Value 22, Momentum 25, each scored against its sector).

- StockRank: 4/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 22, Value 22, Momentum 25: each a 0-100 percentile within Healthcare.
- Position: #25,389 overall, #2,517 in Healthcare.
- Listing: United States, NMS; Healthcare / Biotechnology.
- Last close: 43.42 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors bought USD 1.1M; directors sold USD 20.8M.

Source: https://moatmap.ai/stock/IONS
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker